Trial Profile
Neurocognition and Work Productivity in Major Depressive Disorder.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Apr 2015
Price :
$35
*
At a glance
- Drugs Desvenlafaxine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 09 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 31 Jul 2013 Planned end date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 25 Jan 2012 Actual initiation date (January 2012) added as reported by ClinicalTrials.gov.